FDA
- Status: approved
Ipratropium Bromide 20Micrograms Inhaler (Ipratropium Bromide 20Micrograms Inhaler) regulatory status in United States.
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. FDA has authorised it.
Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina is the originator. The local marketing authorisation holder may differ — check the official source linked above.